ID
14817
Beskrivning
A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00915369
Länk
https://clinicaltrials.gov/show/NCT00915369
Nyckelord
Versioner (1)
- 2016-04-29 2016-04-29 -
Uppladdad den
29 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Advanced Breast Cancer NCT00915369
Eligibility Advanced Breast Cancer NCT00915369
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
er/pr positive status
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1719706
- UMLS CUI [2]
- C0069515
Beskrivning
her2+ detected with fish/cis
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2316574
Beskrivning
hypersensitivity to paclitaxel or any other taxane
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0215136
Beskrivning
chemotherapy, hormonal therapy immunotherapy, therapy with biologicals or radiotherapy
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0021083
Beskrivning
cns lesions
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0742468
Similar models
Eligibility Advanced Breast Cancer NCT00915369
- StudyEvent: Eligibility
C0205269 (UMLS CUI [1,2])
C0069515 (UMLS CUI [2])
C0215136 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2])